THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 118 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is 7.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $415 | -6.7% | 48,023 | +11.7% | 0.00% | – |
| Q2 2023 | $445 | +8.0% | 42,980 | +13.4% | 0.00% | – |
| Q1 2023 | $412 | -0.7% | 37,916 | +2.6% | 0.00% | – |
| Q4 2022 | $415 | -99.9% | 36,968 | -54.1% | 0.00% | – |
| Q3 2022 | $818,000 | +26.6% | 80,577 | +13.0% | 0.00% | – |
| Q2 2022 | $646,000 | +48.8% | 71,313 | +57.0% | 0.00% | – |
| Q1 2022 | $434,000 | -4.4% | 45,408 | +10.6% | 0.00% | – |
| Q4 2021 | $454,000 | +21.4% | 41,061 | -18.8% | 0.00% | – |
| Q3 2021 | $374,000 | -28.1% | 50,561 | +41.1% | 0.00% | – |
| Q2 2021 | $520,000 | -32.6% | 35,837 | -5.1% | 0.00% | – |
| Q1 2021 | $771,000 | -90.3% | 37,774 | -91.5% | 0.00% | -100.0% |
| Q4 2020 | $7,933,000 | -1.4% | 446,451 | -18.0% | 0.00% | 0.0% |
| Q3 2020 | $8,049,000 | -26.9% | 544,380 | +3.8% | 0.00% | 0.0% |
| Q2 2020 | $11,008,000 | -7.4% | 524,461 | +1.9% | 0.00% | -50.0% |
| Q1 2020 | $11,889,000 | -12.8% | 514,469 | -2.3% | 0.00% | 0.0% |
| Q4 2019 | $13,629,000 | +33.5% | 526,438 | +0.5% | 0.00% | +100.0% |
| Q3 2019 | $10,208,000 | -45.1% | 524,014 | -54.0% | 0.00% | -66.7% |
| Q2 2019 | $18,606,000 | -32.2% | 1,139,370 | -5.9% | 0.00% | -25.0% |
| Q1 2019 | $27,453,000 | -13.0% | 1,210,979 | -1.8% | 0.00% | -20.0% |
| Q4 2018 | $31,554,000 | -39.5% | 1,233,062 | -22.7% | 0.01% | -37.5% |
| Q3 2018 | $52,147,000 | +32.1% | 1,596,187 | -8.3% | 0.01% | +33.3% |
| Q2 2018 | $39,481,000 | -30.6% | 1,740,780 | -25.8% | 0.01% | -33.3% |
| Q1 2018 | $56,871,000 | -11.9% | 2,345,195 | +1.3% | 0.01% | -10.0% |
| Q4 2017 | $64,580,000 | -18.0% | 2,315,540 | +0.7% | 0.01% | -23.1% |
| Q3 2017 | $78,762,000 | +49.8% | 2,300,296 | +74.3% | 0.01% | +44.4% |
| Q2 2017 | $52,567,000 | +293.6% | 1,319,441 | +263.7% | 0.01% | +200.0% |
| Q1 2017 | $13,356,000 | +45.3% | 362,735 | +25.8% | 0.00% | +50.0% |
| Q4 2016 | $9,193,000 | -19.6% | 288,365 | -8.5% | 0.00% | 0.0% |
| Q3 2016 | $11,427,000 | +139.0% | 315,323 | +49.6% | 0.00% | +100.0% |
| Q2 2016 | $4,782,000 | +105.9% | 210,763 | +70.6% | 0.00% | – |
| Q1 2016 | $2,323,000 | +3.9% | 123,563 | -9.4% | 0.00% | – |
| Q4 2015 | $2,235,000 | +45.0% | 136,353 | -2.7% | 0.00% | – |
| Q3 2015 | $1,541,000 | -5.1% | 140,175 | +12.4% | 0.00% | – |
| Q2 2015 | $1,623,000 | -24.5% | 124,685 | +0.6% | 0.00% | – |
| Q1 2015 | $2,151,000 | -58.0% | 123,985 | -63.8% | 0.00% | -100.0% |
| Q4 2014 | $5,117,000 | -35.7% | 342,948 | -0.6% | 0.00% | -50.0% |
| Q3 2014 | $7,953,000 | +140.1% | 345,045 | +232.1% | 0.00% | +100.0% |
| Q2 2014 | $3,312,000 | – | 103,896 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |